Heparin sodium and Carotid artery occlusion - a phase IV clinical study of FDA data

Summary:

Carotid artery occlusion is reported as a side effect among people who take Heparin sodium (heparin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Thrombosis.

The phase IV clinical study analyzes which people have Carotid artery occlusion when taking Heparin sodium. It is created by eHealthMe based on reports of 20,987 people who have side effects when taking Heparin sodium from the FDA, and is updated regularly.

What is Heparin sodium?

Heparin sodium has active ingredients of heparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 21,065 Heparin sodium users. Check the latest studies of Heparin sodium.

What is Carotid artery occlusion?

Carotid artery occlusion (artery blockage) is found to be associated with 476 drugs and 566 conditions by eHealthMe. Check the latest studies of Carotid artery occlusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 02, 2026

20,987 people reported to have side effects when taking Heparin sodium.
Among them, 21 people (0.1%) have Carotid artery occlusion.

Could Heparin sodium cause Carotid artery occlusion?

Among these 21 people:

How long have people been on Heparin sodium when they have Carotid artery occlusion? *

What is the gender of people who have Carotid artery occlusion when taking Heparin sodium? *

female: 35.29 %
male: 64.71 %

What is the age of people who have Carotid artery occlusion when taking Heparin sodium? *

What are other drugs people take besides Heparin sodium? *

What are other side effects people have besides Carotid artery occlusion? *

Heparin-Induced Thrombocytopenia: 8 people, 38.10%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 5 people, 23.81%
Hypotension (abnormally low blood pressure): 3 people, 14.29%
Cardiac Failure Congestive: 3 people, 14.29%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 14.29%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 14.29%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 2 people, 9.52%
Cardiac Arrest: 2 people, 9.52%
Haemorrhagic Transformation Stroke (haemorrhages develop inside areas of ischemia): 2 people, 9.52%
Pain In Extremity: 2 people, 9.52%

What are the existing conditions these people have? *

Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 14.29%
Embolism Arterial (blood clot that has travelled through your arteries and become stuck): 2 people, 9.52%
Sleep Disorder: 1 person, 4.76%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.76%
Local Anaesthesia: 1 person, 4.76%
Infection: 1 person, 4.76%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 4.76%
Heart Attack: 1 person, 4.76%
Chest Pain: 1 person, 4.76%
Carotid Arterial Embolus (obstruction in carotid artery): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Heparin sodium and have Carotid artery occlusion?

- Check whether Carotid artery occlusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Heparin sodium:

Heparin sodium (21,065 reports)

Browse all side effects of Heparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Carotid artery occlusion:

Carotid artery occlusion (476 drugs)

Browse all the conditions that are associated with Carotid artery occlusion:

Carotid artery occlusion (566 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium (the active ingredients of Heparin sodium) and Heparin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.